Childhood cancers trials in Israel
44 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
- Where
- Beersheba, Haifa, Jerusalem, Petah Tikva, Petah Tikvah, Ramat Gan, Tel Aviv
- People
- 510 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT05580562 · EU 2022-502051-56-00 - Phase 1/2Not yet taking people in IsraelA Phase 1/2 Study of T-cell Expressing a Novel CD19 Chimeric-Antigen Receptor (SHB-02-CD19) in Patients With CD19-expressing B-cell Malignancies
- Where
- Ramat Gan
- Age
- 1 year to 80 years
- People
- 50
- Run by
- Sheba Medical Center
See details and how to joinNCT07503353 - Phase 2Taking peopleInternational Study for Treatment of High Risk Childhood Relapsed ALL 2010
- Where
- Tel Aviv
- Age
- Up to 17 years
- People
- 250 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT03590171 · EU 2024-513070-21-00 - No phaseTaking peopleOutcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
- Where
- Kefar Sava
- People
- 212 worldwide
- Run by
- Mayo Clinic
See details and how to joinNCT06689956 - Phase 1/2Taking peopleA Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies
- Where
- Ramat Gan
- Age
- 1 year to 80 years
- People
- 50
- Run by
- Sheba Medical Center
See details and how to joinNCT07135466 - Phase 1/2Taking peopleModified Vaccine for High Risk or Low Residual Melanoma Patients
- Where
- Jerusalem
- People
- 50
- Run by
- Hadassah Medical Organization
See details and how to joinNCT01898039 - Phase 1/2Taking peopleHEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
- Where
- Petah Tikva, Ramat Gan
- Age
- 1 year to 21 years
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05658640 · EU 2022-501869-41-00 - Phase 1/2Taking peopleHEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
- Where
- Petah Tikva, Ramat Gan
- Age
- 1 year to 21 years
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05745714 · EU 2022-501867-42-01 - Phase 1/2Taking peopleHEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
- Where
- Petah Tikva, Ramat Gan
- Age
- 1 year to 21 years
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05751044 · EU 2022-501866-22-00 - Phase 3Taking peopleHigh-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
- Where
- Haifa
- Age
- Up to 21 years
- People
- 800 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT04221035 · EU 2024-514917-36-00 - No phaseEnrolling by invitationInternational Registry of Congenital Portosystemic Shunt (IRCPSS)
- Where
- Petach Tikvah
- Age
- 1 day and over
- People
- 500 worldwide
- Run by
- Prof. Valérie Mc Lin
See details and how to joinNCT06041906 - Phase 2Taking peopleA Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- Where
- Haifa, Petah Tikva, Ramat Gan
- Age
- 6 months to 25 years
- People
- 141 worldwide
- Run by
- Day One Biopharmaceuticals, Inc.
See details and how to joinNCT04775485 · EU 2024-510691-20-00 - Phase 3Taking peopleTreatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
- Where
- Beersheba, Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
- Age
- Up to 17 years
- People
- 5,000 worldwide
- Run by
- Martin Schrappe
See details and how to joinNCT03643276 · EU 2023-509856-32-00 - No phaseTaking peopleE²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
- Where
- Ramat Gan
- Age
- 12 years and over
- People
- 2,000 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT03818503 - Phase 3Taking peopleStudying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML
- Where
- Petah Tikva
- Age
- Up to 18 years
- People
- 170 worldwide
- Run by
- Vastra Gotaland Region
See details and how to joinNCT05477589 - Phase 1/2Taking peopleFaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
- Where
- Haifa, Jerusalem, Petah Tikva, Tel Aviv, Tel HaShomer
- People
- 1,672 worldwide
- Run by
- University of Birmingham
See details and how to joinNCT04625907 · EU 2024-510579-40-00 - Phase 2Taking peopleTreatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
- Where
- Haifa
- Age
- Up to 18 years
- People
- 89 worldwide
- Run by
- Associazione Italiana Ematologia Oncologia Pediatrica
See details and how to joinNCT04793919 · EU 2024-518669-83-00 - No phaseTaking peopleTreatment for Classical Hodgkin Lymphoma in Children and Adolescents
- Where
- Petah Tikva
- Age
- 1 month to 18 years
- People
- 2,200
- Run by
- GALIA AVRAHAMI
See details and how to joinNCT02797717 - No phaseTaking peopleAssessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma
- Where
- Jerusalem
- People
- 250
- Run by
- Hadassah Medical Organization
See details and how to joinNCT01438658